BioArctic is a biopharmaceutical company that develops new innovative drugs based on pioneering research that improves the lives of patients with central nervous system disorders.
The goal is to generate transformative drugs for a global market that can stop or slow down the development of diseases, mainly Alzheimer’s and Parkinson’s diseases.
STATUS: Exit
